Systemic lupus erythematosus

Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis

Chi Chiu Mok, Ling Yin Ho, Shirley King Yee Ying, Man Chi Leung, Chi Hung To, Woon Leung Ng

10.1136/annrheumdis-2020-217178

May 24, 2020

Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort

Francesca Saccon, Margherita Zen, Mariele Gatto, Domenico Paolo Emanuele Margiotta, Antonella Afeltra, Fulvia Ceccarelli, Fabrizio Conti, Alessandra Bortoluzzi, Marcello Govoni, Giulia Frontini, Gabriella Moroni, Francesca Dall'Ara, Angela Tincani, Viola Signorini, Marta Mosca, Anna Chiara Frigo, Luca Iaccarino, Andrea Doria

10.1136/annrheumdis-2020-217070

April 22, 2020

Impact of the new American College of Cardiology/American Heart Association definition of hypertension on atherosclerotic vascular events in systemic lupus erythematosus

Konstantinos Tselios, Dafna D Gladman, Jiandong Su, Murray Urowitz

10.1136/annrheumdis-2019-216764

March 10, 2020

Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach

John G Hanly, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sanchez-Guerrero, Sasha Bernatsky, Ann E Clarke, Daniel J Wallace, David A Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askanase, Vernon Farewell

10.1136/annrheumdis-2019-216150

January 8, 2020

IFN-α kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study

Frederic A Houssiau, Aikaterini Thanou, Minodora Mazur, Edgar Ramiterre, Danny Alexis Gomez Mora, Maria Misterska-Skora, Risto Alfredo Perich-Campos, Svetlana A Smakotina, Sergio Cerpa Cruz, Bassem Louzir, Thérèse Croughs, Michael Lucas Tee

10.1136/annrheumdis-2019-216379

December 23, 2019

Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial

Alexis Mathian, Micheline Pha, Julien Haroche, Fleur Cohen-Aubart, Miguel Hié, Marc Pineton de Chambrun, Thi Huong Du Boutin, Makoto Miyara, Guy Gorochov, Hans Yssel, Patrick Cherin, Hervé Devilliers, Zahir Amoura

10.1136/annrheumdis-2019-216303

December 18, 2019

High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus

Sarah Reid, Andrei Alexsson, Martina Frodlund, David Morris, Johanna K Sandling, Karin Bolin, Elisabet Svenungsson, Andreas Jönsen, Christine Bengtsson, Iva Gunnarsson, Vera Illescas Rodriguez, Anders Bengtsson, Sabine Arve, Solbritt Rantapää-Dahlqvist, Maija-Leena Eloranta, Ann-Christine Syvänen, Christopher Sjöwall, Timothy James Vyse, Lars Rönnblom, Dag Leonard

10.1136/annrheumdis-2019-216227

December 11, 2019

Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus

Maria Grigoriou, Aggelos Banos, Anastasia Filia, Pavlos Pavlidis, Stavroula Giannouli, Vassiliki Karali, Dionysis Nikolopoulos, Antigone Pieta, George Bertsias, Panayotis Verginis, Ioannis Mitroulis, Dimitrios T Boumpas

10.1136/annrheumdis-2019-215782

November 28, 2019

In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment

Christina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, Alessandra Bortoluzzi, Antonis Fanouriakis, Emmanouil Papastefanakis, Eleni Kalogiannaki, Irini Gergianaki, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias

10.1136/annrheumdis-2019-216155

November 8, 2019

NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus

Petrus Linge, Sabine Arve, Lina M Olsson, Dag Leonard, Christopher Sjöwall, Martina Frodlund, Iva Gunnarsson, Elisabet Svenungsson, Helena Tydén, Andreas Jönsen, Robin Kahn, Åsa Johansson, Lars Rönnblom, Rikard Holmdahl, Anders Bengtsson

10.1136/annrheumdis-2019-215820

November 8, 2019